Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Panbela Therapeutics, Inc. Common Stock (PBLA)

Pharmaceutical Preparations

https://www.panbela.com

Panbela Therapeutics Inc is a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company's pipeline assets are ivospemin (SBP-101), FlynpoviTM (eflornithine (CPP-1X) and sulindac), and eflornithine (CPP-1X), which provide a multi-targeted approach to reset dysregulated biology present in many types of diseases such as cancer and autoimmunity.

712 VISTA BLVD #305
WACONIA, MN

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/29/2014

Market Cap

1,603,075

Shares Outstanding

480,000

Weighted SO

480,404

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

ZVSA --.--%

SONN --.--%

REVB --.--%

NAVB --.--%

CYTO --.--%

PALI --.--%

VRAX --.--%

QNRX --.--%

UNCY --.--%

Beta

0.9190

Last Div

0.0000

Range

0.3-38.0

Chg

-0.0398

Avg Vol

18725

Mkt Cap

1603075

Exch

NASDAQ

Country

US

Phone

952 479 1196

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.0559

P/FV

-151.6914

Div Yield %

0.0000

P/E

-56.1222

PEG

0.1193

Payout

0.0000

Current Ratio

0.0460

Quick Ratio

0.0460

Cash Ratio

0.0035

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

175.5247

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0061

ROA

-3.0342

ROE

5.4545

ROCE

6.1931

NI/EBT

0.9939

EBT/EBIT

0.6293

EBIT/Rev

0.0000

Debt Ratio

0.1062

D/E

-0.0946

LT Debt/Cap

0.0000

Total Debt/Cap

-0.1045

Int Coverage

-9133.6000

CF/Debt

-24.8900

Equity Multi

-0.8908

Rec Turnover

0.0000

Pay Turnover

2.0795

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.0051

FCF/Share

-0.0051

Cash/Share

0.0000

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

-24.8900

ST Coverage

-24.8900

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

-151.6914

P/B

-151.6914

P/S

0.0000

P/E

-56.1222

P/FCF

-0.0644

P/OCF

-64.4064

P/CF

-64.4064

PEG

0.1193

P/S

0.0000

EV Multiple

-0.0559

P/FV

-151.6914

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 21, 09:15 Panbela Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $2.0 Million Gross Proceeds Priced At-the-Market Benzinga Dec 19, 13:34 Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session MarketWatch Dec 19, 12:53 Panbela Therapeutics' stock soars on positive FDA news on child cancer treatment MarketWatch Dec 19, 12:53 Panbela Therapeutics' stock soars on positive FDA news on child cancer treatment GlobeNewswire Inc. Nov 03, 07:55 Panbela Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.9 Million Gross Proceeds Priced At-the-Market PennyStocks Oct 25, 09:19 5 Hot Penny Stocks To Watch In The Stock Market Today

Revenue Product Segmentation